Additionally, it addresses the FDA’s communications Along with the applicant, the retention of documents that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer ownership of an SE report to a whole new applicant and electronic submission on the SE report an